Skip to Main Content

What does taking part in these studies involve?

It involves entry into the ADVN Registry study. In this study, we will collect your health information and a small amount of blood. In addition, we will ask you to agree to be contacted in the future to see if you are interested in taking part in other ADVN studies.

If you agree to take part in other ADVN studies, a skin biopsy may be needed.

Step 1: Do you qualify for one of these studies?

The screening information below is the first step in determining if you are qualified for these studies. Carefully review "Who may participate in these studies." If you meet the criteria and you are interested, you can indicate your interest by proceeding to Step 2.

Who may participate in these studies?

  • Males and females of any race who have active AD
  • Males and females of any race who have outgrown AD (even if it has been inactive for many years)
  • 1 to 80 years of age
  • No other serious illness
  • Those under age 18 must have a parent or legal guardian provide informed consent on their behalf
  • Even though we are enrolling people regardless of race and ethnicity, we have a special need to enroll African Americans in these studies because they may be at greater risk. This risk may be related to a different genetic background.

Step 2: How to indicate interest in these studies

Participating in these studies is your choice. If you are interested in participating in these studies, please call the Center nearest you or our toll free number 1-888-413-5852.

Participating Centers

National Jewish Health, Denver, CO
Phone: 303-398-1067, e-mail TaylorP@njc.org

Oregon Health & Science University, Portland, OR
503-228-7350, e-mail keenem@ohsu.edu

University of California at San Diego, San Diego, CA
858-657-8390, e-mail derm@ucsd.edu

Children’s Hospital Boston, Boston, MA
617-355-6127, e-mail advnstudy@childrens.harvard.edu

Johns Hopkins Hospital, Pediatric Immunology, Baltimore, MD
410-614-5467, e-mail krimell1@jhmi.edu

University of Rochester, Rochester, New York
585-275-0374, e-mail ADVN@urmc.rochester.edu

What will you receive for your participation?

  • Study related medical evaluation, including physical exam
  • Education and information about atopic dermatitis
  • Financial compensation for qualified participants

This project has been funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract No. HHSN266200400029C.

Especially Needed

Individuals with active AD or who have outgrown AD and also have a history of widespread herpes virus skin infection (also called eczema herpeticum), molluscum contagiosum (pearly wart-like skin lesions), or eczema vaccinatum (adverse reaction to smallpox vaccination).

Even though we are enrolling people regardless of race and ethnicity, we have a special need to enroll African Americans in these studies because African Americans may be at a greater risk.  This risk may be related to a different genetic background.

Where Can I Participate?

During the next five years, doctors at the following sites will be conducting clinical studies designed to make smallpox vaccinations safer for millions of people:

Please call 1-888-413-5852 if you have questions.